Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Medical Student Investigates Opioid Prescription Practices in Sickle Cell Disease
Clinical Breakthroughs

Medical Student Investigates Opioid Prescription Practices in Sickle Cell Disease

By Anna WilliamsNov 30, 2016
Share
Facebook Twitter Email
leslieokorjistudentimage
Fourth-year medical student Leslie Okorji was the first author of a paper showing that opioid prescription practices vary for children discharged after a sickle cell disease pain episode.

Opioid prescription practices vary for children discharged after a sickle cell disease pain episode, and standardized guidelines are needed, according to a recent Northwestern Medicine study.

Fourth-year medical student Leslie Okorji was the first author of the paper, published in the journal Pediatric Blood & Cancer. He conducted the research under senior author Robert Liem, ’97 MD, ’01 GME, associate professor of Pediatrics in the Division of Hematology, Oncology and Stem Cell Transplantation.

Sickle cell disease (SCD) is an inherited blood disorder, most prevalent in people of African descent, in which abnormal hemoglobin distorts red blood cells into a crescent shape. These “sickle cells” can clog blood vessels and interfere with the delivery of oxygen, resulting in organ damage and periods of intense pain.

These acute pain episodes are one of the most common reasons children with SCD are hospitalized or visit the emergency department (ED). But there are currently no evidence-based guidelines for how to manage pain in these patients following discharge.

“We need to understand these patients better, especially because the literature suggests that the typical patient with sickle cell disease is under-prescribed pain medication,” Okorji said. “But we know these patients have a real, physiological reason for pain and live with pain at home.”

In the study, the investigators sought to determine what impact different prescription practices had on return visits for persistent pain. They hypothesized that scheduled opioid prescriptions at discharge — compared to as-needed prescriptions or no opioids at all — would be associated with fewer return visits to the ED or hospital within 30 days.

They performed a five-year retrospective study, analyzing electronic medical records of children with SCD who were hospitalized or discharged from the ED at Ann & Robert H. Lurie Children’s Hospital of Chicago.

The data, surprisingly, showed there was no association between frequency of opioid prescription and return to care within 30 days.

However, patients who were discharged from the ED had an increased likelihood of returning within that time frame, compared to those who were admitted to the hospital.

The study also found that, of patients who were seen in the ED and then released, those who received nonsteroidal anti-inflammatory drugs at discharge were more likely to return to the ED within 30 days, compared to those who were given an opioid prescription.

“This suggests that perhaps future guidelines should make sure these patients who come to the ED with mild-to-moderate pain and then are released get some kind of opioid coverage,” Okorji explained. “That way, they don’t have to come back to the ED for something that could be managed at home.”

He also stressed the importance of continued research. “This study opened up the discussion, but was limited by the retrospective nature of the analysis,” Okorji said. “The overall message is that we need more prospective studies in order to get complete evidence-based guidelines.”

In December 2015, Okorji presented preliminary results of the study at the 57th American Society of Hematology Annual Meeting in Orlando, Florida.

Okorji, who was born and raised in Nigeria, plans to enter into a urology residency after graduation. Encouraged by his mentor, Robert Brannigan, MD, professor of Urology, Okorji has also published two papers this year in the journal Urology Case Reports. “That’s one of the things I’ve really appreciated about being here,” he said. “If you want to do research, it’s easy to do at Feinberg.”

Medical Education Pediatrics Research Students
Share. Facebook Twitter Email

Related Posts

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Comments are closed.

Latest News

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.